Celiac.com 12/24/2014 - Market research firm RNRMarketReseach has announced the release of its EpiCast Report: Celiac Disease - Epidemiology Forecast to 2023.

Image: Wikimedia Commons--John William WaterhouseWritten and developed by Masters and PhD-level epidemiologists, the EpiCast Report uses literature review and primary research results, consistent definitions and methodology to offer in-depth, high quality, transparent and market-driven analysis of celiac disease trends in the six major markets (6MM) of the US, France, Germany, Italy, Spain, and UK through 2023.

The report provides an overview of the risk factors, comorbidities, and the global and historical trends for celiac disease in these markets.

The report also includes a 10-year epidemiological forecast for the total prevalent cases of celiac disease segmented by sex and age (0-19 years, 20-29 years, 30-39 years, 40-49 years, 50-59 years, 60-69 years, and over 70 years), along with a 10-year epidemiological forecast for the diagnosed prevalent cases of celiac disease in the 6MM.

The report includes forecast data on the number of total prevalent cases of celiac disease in the 6MM, which it projects to grow at a rate of 3.92% per year, to a total of more than 8 million cases, through 2023.

The report also projects the number of diagnosed prevalent cases in the 6MM to increase by 4.61% over the next decade to 1.11 million cases in 2023.

Anyone interested in the details may purchase a copy at EpiCast Report: Celiac Disease – Epidemiology Forecast to 2023.

Celiac.com welcomes your comments below (registration is NOT required).